Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction 
Company name: Dechra Veterinary Products Limited
Address: (A business unit of Dechra Pharmaceuticals PLC)
Sansaw Business Park
Hadnall, Shrewsbury
Shropshire SY4 4AS
Telephone: 01939 211200
Fax: 01939 211201
Email: info@dechra-uk.com
Website: www.dechra.com
Presentation
White, circular, biconvex, flat-faced tablets with bevelled edges and a breakline.
Each tablet contains:
Active substance: Frusemide/Furosemide 40 mg
Uses
Frusedale® 40 mg oral tablets are for use in cats and dogs only, for the treatment of oedema associated with cardiac insufficiency, renal dysfunction and trauma.
In animals with pulmonary oedema of cardiac origin, combined therapy with other medicinal products may be indicated.
Frusemide is a potent loop diuretic with an onset of activity normally within 1 hour of administration and a duration of activity of approximately 4 hours.
Dosage and administration
For oral administration only. Cats and dogs above 4 kg body weight:
Dosage up to 5 mg/kg body weight, or one Frusedale® 40 mg oral tablet per 8 kg body weight, 1-2 times daily with an interval of 6 to 8 hours between administrations.
For animals weighing between 4 and 8 kg, one half of one tablet should be administered. The tablets may be divided by breaking along the score line. For maintenance, the dosage should be reduced to 1-2 mg/kg per day.
Contraindications, warnings, etc
If you notice any serious effects or other effects not mentioned in the data sheet, please inform your veterinary surgeon.
Do not use in animals weighing less than 4 kg.
Do not use in animals with acute glomerular nephritis, renal failure with anuria, electrolyte deficiency disease or in animals that have received an overdosage of digitalis.
Do not exceed the recommended dosage.
Therapeutic efficacy may be impaired by increased intake of drinking water. Where the animal's condition permits, water intake should be restricted during treatment with Frusedale® 40 mg oral tablets.
Monitoring of plasma potassium levels is advisable during periods of prolonged treatment of combined therapy with cardiac glycosides. Potassium supplements may be necessary.
Do not use concurrently with aminoglycoside antibiotics or corticosteroids.
Concurrent administration with aminoglycoside antibiotics may result in ototoxicity.
Concurrent use of corticosteroids may increase the risk of hypokalaemia.
Concurrent administration with cephalosporin antibiotics may result in nephrotoxicity. Concurrent administration with digoxin enhances the cardiac glycoside. Concurrent administration with sulphonamide antibacterials may result in sulphonamide allergy.
Administration at the recommended dosage level is not normally associated with undesirable effects.
Frusedale® 40 mg oral tablets may be used in pregnant or lactating animals.
Overdose: Transitory deafness may occur in animals administered the product at doses higher than those recommended. Cardiovascular side effects may occur in weak and old animals following overdosage. Excessive doses can lead to hypovolaemia and decompensate renal function. Management of signs of overdosage is symptomatic.
Special precautions to be taken by the person administering the veterinary medicinal product to animals: Wear gloves, or wash your hands immediately after handling the tablets.
General precautions: For animal treatment only.
Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Do not use after the expiry date stated on the label.
Disposal: Dispose of unused product and empty containers in accordance with guidance from your local waste regulation authority.
Legal category
POM-V
Packaging quantities
Plastic containers of 1000 tablets.
Further information
To be supplied only on veterinary prescription.
UK authorised veterinary medicinal product.
Marketing authorisation holder (if different from distributor)
Dechra Limited, Dechra House, Jamage Industrial Estate, Talke Pits, Stoke-on-Trent, Staffordshire, ST7 1XW.
Marketing authorisation number
Vm 10434/4033.
| 
